Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_02196 |
| Species: | Mus musculus |
| Position : | chr11:112217279-112217835 |
| Year: | 2026 |
| Title: | A single-nucleotide enhancer mutation overrides chromosomal sex to drive XX male development |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 41957362 |
| MONDO: | |
| Tissue: | Gonad |
| Tissue Ontology ID: | UBERON:0000991 |
| Cell Source: | Embryonic gonadal cells |
| CVCL ID: | |
| Cell Type: | embryonic gonad cell |
| Cell Ontology ID: | CL:0000000 |
| Experiment Type: | Enhancer activity assay, TF binding assay, Functional perturbation assay |
| High Throughput Method: | RNA-seq, ATAC-seq |
| Low Throughput Method: | Luciferase Reporter Assay, CRISPR Knockout, EMSA, qRT-PCR |
| Target gene : | Sox9 |
| TF name : | Sox9 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| Sox9 | Deactivation of the beta-catenin transactivating complex | reactome | 42 |
| Sox9 | TGF_beta_Receptor | netpath | 220 |
| Sox9 | Hs_Neural_Crest_Differentiation_WP2064_79263 | wikipathways | 40 |
| Sox9 | Hs_Spinal_Cord_Injury_WP2431_87678 | wikipathways | 21 |